论文部分内容阅读
目的 评价黏质沙雷氏菌苗 (S311)治疗恶性胸腔积液的疗效及毒副反应。方法 取S31110 9U(0 .32mg)于第 1,8,15天注入胸腔。观察 4周 ,评价疗效和毒副反应。结果 34例患者中 ,完全缓解 (CR) 12例 ,部分缓解 (PR) 2 1例 ,总有效率 97.1% (33/ 34)。毒副反应较轻 ,有发热 (82 .4 % )、胸痛 (5 2 .9% )、恶心 (2 6 .5 % )、呼吸困难 (17.5 % )、寒战 (5 .9% )及呕吐 (2 .9% )。结论 S311治疗恶性胸腔积液疗效较好 ,毒副反应可以耐受 ,可以安全用于临床。
Objective To evaluate the curative effect and toxicity of Serratia marcescens vaccine (S311) in the treatment of malignant pleural effusion. Methods S31110 9U (0.32mg) was injected into the thoracic cavity on day 1,8,15. Observed for 4 weeks to evaluate the efficacy and toxicity. Results Of the 34 patients, there were 12 cases of complete remission (CR) and 21 cases of partial remission (PR). The total effective rate was 97.1% (33/34). Toxic side effects were mild with fever (82.4%), chest pain (52.9%), nausea (26.5%), dyspnea (17.5%), chills (5.9%) and vomiting 2 .9%). Conclusion The efficacy of S311 in the treatment of malignant pleural effusion is good and the side effects can be tolerated. It can be safely used clinically.